Navigation Links
Women & Infants site for premiere of softer hospital gowns called 'Janes'
Date:9/5/2012

onth development process. She held focus groups at The Breast Health Center, turned to her sisters, relied on input from a radiologist with 30 years experience in woman's imaging, and then collaborated with folks at Purity Linen, the laundry company that services Women & Infants, to test the durability of the fabric.

The off-white gowns with peach trim are made of a waffle-weave jersey fabric that will trap warmth next to the wearer's skin and be soft enough if rubbing against surgical sites. Designed for use during out-patient experiences patient examinations or chemotherapy treatments, for example Jane looks more like a robe, wrapping in the front with a generous overlap for complete coverage and a pocket. They come in two sizes for comfort.

"We are thrilled at The Breast Health Center to be able to offer our patients the latest design in patient gowns," says Robert D. Legare, MD, director of The Breast Health Center. "We have always acknowledged the inherent dignity of each patient and believe the Janes will help us further preserve this dignity during all patient encounters."


'/>"/>

Contact: Susan McDonald
slmcdonald@wihri.org
401-681-2816
Women & Infants Hospital
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Taller, Heavier Women May Face Higher Ovarian Cancer Risk
2. 62 percent of men and 37 percent of women over the age of 65 are sexually active
3. Obese White Women Shying Away From Colon Cancer Screening
4. Study: Women not getting enough exercise; at risk of developing metabolic syndrome
5. Timing pregnancy an important health concern for women
6. White Women Make Up Bulk of Assisted-Living Residents
7. Stress contributes to cognitive declines in women with breast cancer, researcher says
8. Women Less Apt Than Men to Get Recommended Daily Exercise
9. Overweight Pregnant Women at Higher Risk for Complications
10. Women With Older Partners More Often Admitted to Nursing Homes
11. Research shows efficacy of treatment model developed at Women & Infants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Chicago, IL (PRWEB) , ... September 01, 2015 ... ... Traumeel™ and Zeel™, has recently sponsored an educational workshop for physician assistants (PAs) ... I.A. Injections of Traumeel™ and Zeel™” was held by Dr. Erick Salado, an ...
(Date:9/1/2015)... Toronto, ON (PRWEB) , ... September 01, 2015 ... ... Trade Secrets, a leading retailer of professional hair salons. This highly anticipated partnership ... all of the Curl Keeper™ Styling Collection. Founder Jonathan Torch and the Curly ...
(Date:8/31/2015)... ... 2015 , ... Jvion, the Atlanta-based leader in predictive analytic ... on helping hospital perform under the Center for Medicare & Medicaid Services’ (CMS’s) ... on performance across four domains related to care quality. To receive a reward ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dental ... Western University of Health Sciences to learn more about its integrated approach to ... Dental Sciences and Institute of Cellular Medicine at Newcastle University, and Susan Bissett, ...
(Date:8/31/2015)... ... August 31, 2015 , ... India Network Foundation, a non-profit ... tool, which summarizes all available plans, plan maximums, pre-existing condition coverage limits and ... help India Network members make an informed decision regarding the care they want ...
Breaking Medicine News(10 mins):Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 2Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 3Health News:Curly Hair Solutions™ Partners With Trade Secrets 2Health News:Jvion Releases Value-Based Purchasing Predictive Use Case 2Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4Health News:India Network proudly launches the new InstantQuote tool to help choose right visitor health insurance with pre-existing conditions to US bound visitors 2
... Like general anesthesia without the risksCORONA DEL ... (GA) remains a popular anesthetic for cosmetic ... avoid GA for cosmetic surgery. Unfortunately, the ... behind these safety-first visionaries.The public should not ...
... Feb. 24 Early detection is the key ... as immunoassay testing are,facing fierce competition from evolving ... immunohistochemistry testing. The ability,to prove the clinical ... a,laboratory is one of the essential requirements to ...
... for the company, PercipEnz Technologies, Inc. announces the ... for clinical and translation research data exchange. The ... of the available services and acts as an ... the needs of the cancer centers and multi-disciplinary ...
... efficient, accurate translation and localization services focused on quality and ... it has initiated a new program of adding global business reference material ... existing clients. , ... Chicago, IL (Vocus) February 24, 2009 -- Businesses ...
... track pace, time, distance, and more with Nike+ iPod technology, even when ... Inc will adapt the Nike+ iPod technology to whatever shoe the user ... ... Rock Products, Inc. has released their Universal Nike+ Sensor adapter, called "the ...
... For over a decade starting in 1982, Dr. W. ... in his seminars worldwide. There must now be hundreds ... or have observed the Red Bead Experiment somewhere in ... it is important to document the reactions, feelings and ...
Cached Medicine News:Health News:Cosmetic Surgery: PK Anesthesia Safest Achievable 2Health News:Frost & Sullivan: Novel Diagnostics Methods Driving the European Cancer IVD Market Towards Early Detection and Prevention 2Health News:Frost & Sullivan: Novel Diagnostics Methods Driving the European Cancer IVD Market Towards Early Detection and Prevention 3Health News:Frost & Sullivan: Novel Diagnostics Methods Driving the European Cancer IVD Market Towards Early Detection and Prevention 4Health News:Crescendo(tm), the Clinical and Translational Research Exchange, is Launched 2Health News:Crescendo(tm), the Clinical and Translational Research Exchange, is Launched 3Health News:Crescendo(tm), the Clinical and Translational Research Exchange, is Launched 4Health News:Argo Translation Adds New Resources for Conducting Global Business to ArgoTrans.com 2Health News:The Nike+ iPod Sensor Can Be Used by Any Runner with the New Bean Pod.* 2Health News:The Nike+ iPod Sensor Can Be Used by Any Runner with the New Bean Pod.* 3Health News:Wanted - Past Players of Dr. Deming - Red Bead Experiment 2Health News:Wanted - Past Players of Dr. Deming - Red Bead Experiment 3
(Date:8/31/2015)... , Aug. 31, 2015 With ... cytometry is experiencing a rise in active partnerships. ... in underdeveloped nations to quantitate CD4 cell markers ... Logo - http://photos.prnewswire.com/prnh/20150831/262206LOGO ... the Global Flow Cytometry Market ( http://www.frost.com/nf0e ), ...
(Date:8/31/2015)...  The departments of Drug and Alcohol Programs (DDAP) ... 90 to raise awareness for International Overdose Awareness Day ... Pennsylvania and help more Pennsylvanians with substance ... the Building Bridges to Recovery initiative. ... to a disease that is fully treatable, if given ...
(Date:8/31/2015)... Pharmacy, Inc. (NYSE: DPLO ), the nation,s largest independent ... & CEO, and Sean Whelan , CFO, will present ... and Mr. Whelan are scheduled to participate in the Wells ... on Wednesday, September 9, 2015 at 1:45 PM ET. ... participate in the Robert W. Baird 2015 Healthcare Conference in ...
Breaking Medicine Technology:Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 4Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2Diplomat to Participate in Upcoming Investor Conferences 2
... LOS ANGELES--(BUSINESS WIRE)--May 21, 2007 - Cougar Biotechnology,Inc. ... Phase,II data on the Company's prostate cancer drug ... Urological,Association (AUA) Annual Meeting, which is currently taking ... Dr. Timothy A.,Yap from the Cancer Research UK ...
... WIRE)--May 21, 2007 - Medical,professionals seeking to ... gram-negative pneumonia may have a new weapon:,NKTR-061 ... by Nektar Therapeutics (Nasdaq:NKTR)., Results of a ... of,NKTR-061 (Inhaled Amikacin) to treat mechanically ventilated,patients ...
Cached Medicine Technology:Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 2Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 3Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 5Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 6Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 7Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 8Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 9Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 10Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 11